Showing posts with label cancer. Show all posts
Showing posts with label cancer. Show all posts

Cancer fully eliminated

Scientists from the UK are with the experimental therapy called 'Trojan horse' completely remove cancer from a mouse.


Scientists cancer cells have invaded from the tens of thousands of viruses that have come through the immune system to the tumor.

Using viruses to kill cancer cells is a new branch in tumor therapy, and one of the challenges is to get deep inside the tumor viruses so that they can act.

Researchers their study, published in the journal Cancer Research, rated this as 'exciting', but still need to do testing on humans.

After a 40-day 'Trojan horse' therapy, all mice that were used in the experiment were alive and their tumor was withdrawn.
Read more...

Testimony of Dr. Laura S. Welch - part II

OVERVIEW OF ASBESTOS RELATED DISEASE

"There are several medical diseases that occur as a result of asbestos exposure. The ones of greatest concern and importance are pleural plaques and thickening; asbestosis; lung cancer; colon, laryngeal, pharyngeal cancer; and mesothelioma. For many workers, these diseases are disabling or fatal. For each disease there is a standard set of tests, and generally accepted criteria, for diagnosis.

Pleural Plaques and Thickening
Pleural plaques are also called pleural fibrosis, pleural thickening, and pleural asbestosis. A majority of persons with heavy exposure to asbestos develop pleural abnormalities. The pleura is a thin lining that surrounds the lung. Asbestos fibers that are breathed into the lung are transported to the outside of the lung and cause a scar to form in the pleural lining. When these scars reach a certain size they are visible on chest x ray as a plaque.

Most of these plaques alone do not cause disability, but they do tell us that significant exposure has occurred, and that other asbestos related diseases may be present. However, some types of plaques can cause loss of lung function. Scars that involve the costophrenic angle, the angle between the base of the lung and the diaphragm, can cause loss of lung function, as can extensive plaques on both sides of the lung.

Parenchymal Asbestosis (Pulmonary Asbestosis)
Parenchymal asbestosis is a scar formation in the substance of the lung itself. These scars can interfere with lung function, for they block the transport of oxygen from the air in the lungs into the blood vessels that travel through the lungs. Oxygen can only cross the membranes of the lung if they are thin; asbestosis causes them to thicken. As a general rule the greater the exposure the more the disease, i.e. there is a dose-response relationship between exposure and disease. However, some people seem to form scars more readily and so we see a variety of disease from the same level of exposure. These scars are visible on x ray in most cases but certainly not all cases. High resolution CT scan of the chest can find disease not seen on a plain chest x-ray, and is becoming an important component of the standard practice for the diagnosis of asbestosis. The International Labor Organization developed a way of grading chest x-rays for dust diseases of the lung. The most recent version is the1980 Classification of the Radiographic Appearance of Pneumoconioses (dust diseases of the lung). This system is accepted around the world. It provides a standard notation, so that if one reader calls a film a “1/1” another reader will know what the first reader is referring to. The classification uses a 12-point scale to define the degree, or severity, of increased lung markings. Classification of pleural changes (involvement of the membrane lining the chest wall and the lung) uses a separate scale, with specific notations made for side of the chest, whether or not the plaques contain calcium deposits, and the specific type, length, and width of the thickening of the pleura.

This 12-point scale runs from 0/- to 3/+; a “0” film is normal and a “3” film is the most severe scarring. Each reading on the scale is characterized by a number between 0 and 3, and a second number, separated by “/”. The first number, preceding the “/”, is the final number assigned to that film by that reader. The second number, following the “/”, is a qualifier. The numbers 0, 1, 2, and 3 are the main categories. An x-ray read as a category 1 film might be described as 1/0, 1/1, or 1/ 2. When the reader uses 1/1, he is rating the film as a 1, and only considered it as a 1 film. If he uses 1/0, he is saying is rating the film as a “1”, but considered calling it a “0” film before deciding it was category 1. Finally, when the reader uses 1/2, he is saying he is rating the film as a “1”, but did consider calling it a “2” film. In clinical practice, any category “1” film is abnormal; therefore a 1/0 film is consistent with asbestosis.

Even though the ILO system was designed to standardize reading x-rays for asbestosis, studies using the classification in asbestos exposed workers have found readers often disagree about classification of the same x-rays. Using the classification is somewhat of an art. Body size, weight, position of the person during the x-ray, and x-ray technique affect the amount of scarring that is visible on an x-ray. If an x-ray is less than perfect, one reader may think he can be sure scarring is present, while another cannot be sure and grades the film with a lower score for scarring.

The “best” readers agree 80% of the time with each other; 20% of the time they assign a different score to the same x-ray. If the scarring is extensive, a difference of one grade on the scale is not important. But if the x-ray shows less extensive scarring, a difference of one grade can be the difference between making diagnosis of asbestosis or deciding asbestosis is not present. For this reason experts agree that the x-ray alone should not be used to make a diagnosis of asbestosis; the examining physician should use the occupational and medical history, results of pulmonary function testing, and other medical data to reach a diagnosis. Experts also agree that asbestosis can be present in the lung even though the x-ray is normal using the ILO classification system.

High resolution computed tomography (HRCT) is now widely accepted as a diagnostic tool for asbestosis and asbestos-related pleural scarring. HRCT is an excellent technique for diagnosis of asbestosis and asbestos-related plaque. Recent studies show that readers using a scoring index were more accurate and reliable in the diagnosis of asbestosis that when using plain chest x-rays. This study concluded that “the examined HRCT scoring method proved to be a simple, reliable, and reproducible method for classifying lung fibrosis and diagnosing asbestosis also in large populations with occupational disease, and it would be possible to use it as a part of an international classification”. Expert consensus supports this conclusion.

Disease from asbestos is also detected on pulmonary function testing, and PFTs are used to quantity the level of lung impairment due to asbestosis. Asbestosis makes the lung stiffer and smaller, so the volume of air in the lungs is decreased. Oxygen transport as measured by the diffusion capacity is also decreased. Abnormalities are measured using spirometry, lung volumes, and gas exchange testing. Spirometry is reliable and reproducible when performed according to the specifications set by the American Thoracic Society (ATS) . Determination of lung volumes can be done by the gas dilution method or by body plethysmography; both are standard measures and also are reliable and reproducible. The ATS also sets standards for diffusion capacity , which ensure uniformity among laboratories and reproducibility.

Asbestosis can affect each of these tests without necessarily showing an abnormality in the other two. Spirometry and total lung capacity both measure lung volume, but one may be abnormal while the second remains normal. The diffusion capacity measures a decrease in oxygen exchange in the lung, and so is measuring a different function of the lung than lung volumes. Asbestosis can just as easily be manifest with a decreased lung volume or a decrease in gas exchange; neither is a better, more sensitive or more accurate test, and both types of tests must be used in any set of diagnostic criteria. The diffusion capacity has been shown to correlate with the severity of fibrosis found on pathologic examination of the lung, and a reduction in diffusion capacity can precede x-ray changes.

The changes in pulmonary function at times can be subtle, and test results should be interpreted by someone with experience in asbestos related diseases. Pulmonary exercise testing can be used to clarify subtle abnormalities, and any compensation system must allow the examining physician to submit a medical report and rationale based on accepted medical tests. Because the diagnosis of asbestosis or any other asbestos-related disease can be made with a range of medical tests, it is essential that any compensation system include a medical panel to review cases that do not meet the most common diagnostic criteria. As just one example of a study that supports the need for a medical panel, Kipen reported that 18% of insulators who had asbestosis found on pathological examination the lung had a normal chest x-ray . If we were to require a 1/0 film in all cases of asbestosis, these workers would be excluded. Pathological examination is not required in the absence of x-ray abnormalities; a combination of CT scan and exercise testing can reasonably approximate the specificity as tissue examination.

Once this scar formation takes place it is irreversible. It gets worse in some cases, even after exposure stops. Factors that are associated with worsening scarring include the severity of disease (the more the scarring, the more likely it is to get worse), and the amount and intensity of exposure to asbestos. Because of the damage to the lungs a person with asbestosis is at increased risk of lung infections and so should get regular medical care and influenza vaccines."



Testimony of Dr. Laura S. Welch - Part I
Testimony of Dr. Laura S. Welch - Part III
Read more...

Asbestos Claims Trust - Testimony of Dr. Laura S. Welch

Testimony of
Dr. Laura Stewart Welch
Medical Director
Center to Protect Workers Rights
June 4, 2003
(part I)


Testimony of Laura Welch,
MD Medical Director, Center to Protect Workers Rights
On Asbestos Related Diseases – Medical Criteria, Populations at Risk and Disease Projections
Before the Senate Judiciary Committee
June 4, 2003

"Chairman Hatch, Senator Leahy and members of the committee, I want to thank you for the opportunity to appear before the committee to testify on medical and diagnostic criteria for asbestos-related diseases.

MY BACKGROUND
My name is Laura S. Welch. I am a physician, board certified in internal medicine and occupational medicine, licensed to practice here in DC and in Maryland. For many years I have had an active medical practice and treated many workers with asbestos-related disorders. I am currently medical director for The Center To Protect Workers Rights, a research institute affiliated with the Building and Construction Trades department of the AFL-CIO. I am also the author of over 50 peer-reviewed publications and technical reports in the field of occupational and environmental medicine, and am currently an investigator on six research projects in the field. I have served as a consultant to many federal agencies, including OSHA, NIOSH, CDC and the NIH. I have special interest and experience in health and safety in the construction industry. I have worked with several union-management committees on health and safety issues, including Boeing-United Auto Workers, and Rail Management and Rail Labor for the US railroad industry. Since 1987 I have worked with the Sheet Metal Occupational Health Institute (SMOHIT), a labor-management trust for the unionized segment of the sheet metal industry. SMOHIT has sponsored a medical examination program for sheet metal workers in the United States and Canada, to detect occupational lung disease and asbestos-related disease in particular. I have published several papers describing the findings of asbestos-related disease in this group of construction workers , and am now looking at changes in patterns of disease over time in order to project disease rates into the future. Over the past several months I have been participating on behalf of the AFL-CIO in discussions with the Asbestos Study Group, interested insurance companies, and other parties on establishment of an administrative system for asbestos compensation.

THE LEGACY OF ASBESTOS
Decades of uncontrolled use of asbestos, even after its hazards were known, have resulted in an occupational disease crisis in the United States and throughout the world of monumental scope. In this country, from 1940 to 1979, 27.5 million workers were occupationally exposed to asbestos in shipyards, manufacturing operations, construction work and a wide range of other industries and occupations; 18.8 million of these having high levels of exposure . As a result hundreds of thousands of workers and their family members have suffered or died of asbestos-related cancers and lung disease, and more than a million more cases are expected. In this year alone, in 2003, almost 10,000 people in the United States are expected to die from asbestos-related diseases. Because of the long lag between exposure and the development of cancer or other asbestos diseases, the asbestos disease epidemic is only now peaking, and will be with us for decades to come. There is no disputing the fact that many have died of asbestos related disease, and many more will die in the future. Everyone here today must agree that a remedy is needed; we now must agree on what remedy is fair and adequate."


Testimony of Dr. Laura S. Welch - Part II
Read more...

Breast Cancer Online Risk Tool

Early signs of breast cancer

Breast Cancer Online Risk Tool is designed by scientists at the National Cancer Institute (National Institutes of Health) and the National Surgical Adjuvant Breast and Bowel Project (NSABP), to estimate a woman's risk of developing malignant breast neoplasm (breast cancer). This online tool has been updated for African American women based on the CARE Study (Contraceptive and Reproductive Experiences Study), and for Pacific Islander and Asian women in the U. S. based on the AABCS Study (Asian American Breast Cancer Study).


Before using the breast cancer risk calculator, please note the following:

The breast cancer online risk tool was designed to be used by health professionals. If you're not a health professional, we strongly recommend to discuss the results obtained with the breast cancer risk calculator and your personal risk of breast cancer with your doctor.

The breast cancer online risk tool can be periodically updated as new information's or research's becomes available.

This tool should not be used to estimate breast cancer risk for those who have already had a diagnosis of breast cancer, ductal carcinoma in situ (DCIS), or lobular carcinoma in situ (LCIS).


For information to help you to understand cancer risk visit Understanding risk at Cancer.gov. This interactive web site can help you to make informed decisions about the way to lower cancer risk.



Read more...

The Melanoma Online Risk Calculator

This interactive online tool is designed by scientists at the National Cancer Institute (National Institutes of Health), the University of California, San Francisco, and the University of Pennsylvania, to estimate an individual's absolute risk of developing invasive melanoma cancer. This online tool helps clinicians identify individuals at increased risk of melanoma cancer in order to plan necessary screening interventions with that patients.



Before using the melanoma risk calculator, please note the following:

The melanoma online risk tool was designed to be used by health professionals during a physical examination that includes recording of info about the patient's family and personal medical history and an examination of the patient's skin on the shoulders and back. If you're not a health professional, we strongly recommend to discuss the results obtained with the melanoma risk calculator and your personal risk of melanoma cancer with your doctor.

The melanoma online risk calculator can be periodically updated as new information or research becomes available.

This online calculator should not be used to estimate melanoma risk for those who have already had a diagnosis of melanoma, or a family history of melanoma.

Melanoma online tool was developed using information from a large case-control study in the U.S.. Melanoma risks are estimated for non-Hispanic whites only, because information for other ethnicities/races are too limited to accurately estimate the risk of developing melanoma cancer.

For info to help you to understand cancer risk visit Understandingrisk.cancer.gov. This interactive web site can help you to make informed decisions about the way to lower cancer risk.

Based on the risk factor information provided, the Melanoma Risk Online Tool will estimate a person's risk of developing melanoma cancer up to age 70 and in the following five-year period. Risk assessment calculated by this online tool are estimates of absolute melanoma cancer risk.


Read more...

Prostate Cancer - Survival Rates

Doctors usually use survival rates as a standard method of discussing an individual's prognosis (outlook). Some cancer patients may not want to know the survival statistics for individuals in similar situations, while others want to find and know that statistics. If you wish to know read on.

The five-year survival rate refers to the percentage of individual's who live at least 5 years once their cancer is diagnosed. Of course, some of these individuals live much longer than five years, and many of them are cured now.

Five-year relative survival rates, such as the numbers below, assume that some individuals can die of other causes and compare the observed survival with that expected for individuals without the malignant neoplasm (cancer). This is a much better way to see the impact of the malignant neoplasm on survival.


According to the recent information, when including all men with prostate cancer:


  • The five-year relative survival rate is almost 100 percent

  • The ten-year relative survival rate is ninety eight percent

  • The relative 15-year survival rate is ninety one percent


    Keep in mind that five-year survival rates are based on cancer patients diagnosed and first treated over five years ago, and ten year survival rates are based on cancer patients diagnosed over ten years ago. Modern ways of detection and treatment mean that a lot of prostate cancers are now found earlier and may be treated more effectively. If you're diagnosed with cancer this year, your outlook may be higher than the numbers reported above.


    Survival rates by stage
    The NCI(National Cancer Institute) maintains a huge national database on survival statistics for various forms of cancer. This database doesn't cluster malignant neoplasm by AJCC Cancer Staging, but instead groups malignant neoplasm into local, regional, and distant stages.

    - Local stage means that there is no sign that the cancer has metastasized outside of the prostate. This corresponds to stages I and II by AJCC Cancer Staging. About four out of five prostate cancers are found during this early stage.

    - Regional stage means that the cancer has metastasized from the prostate to nearby areas. This includes stage III cancers and also the}stage IV cancers that haven't metastasized to distant body parts, such as T4 tumors and cancers that have metastasized to nearby lymph nodes (N1).

    - Distant stage includes the rest of the stage IV cancers – all cancers that have metastasized to bones, distant lymph nodes, or other organs (M1).

    Cancer Stages by AJCC


    Five-year relative survival rates (%) by stage at the time of diagnosis

    Stage | Five-year relative survival rate

    Local Stage - nearly 100 percent
    Regional Stage - nearly 100 percent
    Distant Stage - twenty ninth percent


    These survival rates can't predict what is going to happen in any specific man's case, and they are based on previous outcomes of huge numbers of men who had the disease.


    Several other factors can have an effect on a man's outlook, like the PSA, the Gleason score, and also the man's overall health. Ask your doctor to tell you how the numbers above may apply to you, as she or he is familiar with the aspects of your specific situation.
  • Read more...
     

    Browse Asbestos Attorney Top Search by City:
    Baltimore | Boston | Charleston | Chicago | Dallas | Greensboro | Houston | Las Vegas | Los Angeles | Louisville | Miami | New York | New Orleans | Oakland | Portland | Philadelphia | Pittsburgh | Phoenix | Richmond | Sacramento | San Antonio | San Diego | San Francisco | Salt Lake City | Seattle | St. Louis

    Browse Asbestos Mesothelioma Attorney By State:
    Alabama | Alaska | Arizona | Arkansas | California | Colorado | Connecticut | Delaware | District Of Columbia | Florida | Georgia | Hawaii | Idaho | Illinois | Indiana | Iowa | Kansas | Kentucky | Louisiana | Maine | Maryland | Massachusetts | Michigan | Minnesota | Mississippi | Missouri | Montana | Nebraska | Nevada | New Hampshire | New Jersey | New Mexico | New York | North Carolina | North Dakota | Ohio | Oklahoma | Oregon | Pennsylvania | Puerto Rico | Rhode Island | South Carolina | South Dakota | Tennessee | Texas | Utah | Vermont | Virginia | Washington | West Virginia | Wisconsin | Wyoming


    | Mesothelioma Attorneys Profiles | Prepare for Mesothelioma Lawsuit | Mesothelioma Attorney Directory | Video | Useful links |

    Thank you for your visit. This website is devoted to the needs of people diagnosed with asbestos mesothelioma cancer. The information provided by us was not prepared by medical professionals and should not be taken as a substitute for medical advice, diagnosis or treatment. We continually research new information about mesothelioma, regularly update the Mesothelioma Attorney Directory, and update information on website. Please, take content of our website ONLY for info.
    | TOS | Privacy Policy